No Data
No Data
Serina Therapeutics(SER.US) Director Buys US$900 in Common Stock
$Serina Therapeutics(SER.US)$ Director Bailey Gregory purchased 100 shares of common stock on May 20, 2024 at an average price of $9 for a total value of $900.Source: Announcement What is statement of
SCPX, XTIA and CRVO Among Mid-day Movers
Express News | Serina Therapeutics And Enable Injection Announced A Partnership To Develop And Commercialize SER-252 (POZ-apomorphine) In Combination With Enfuse For The Treatment Of Parkinson's Disease
Express News | Serina Therapeutics Inc: Enable Will Also Be Entitled to Product Sales and Single Digit Royalties.
Express News | Serina Therapeutics Inc: Will Obtain a Worldwide, Exclusive License to Enfuse Platform for an Upfront and Future Milestone Payments
Express News | Serina Therapeutics Inc - Plans to Advance Ser-252 to Clinical Testing in 2025
No Data